Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for elderly ERCP anesthesia
ChiCTR2300075032Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Dalian Medical University
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in None (4 arms), sponsored by The Second Affiliated Hospital of Dalian Medical University. Primary endpoint: Mean arterial pressure. Started Aug 2023; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2300075032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300075032.